Novavax asks EU regulator to clear vaccine for teens

Tribune Web Desk

Updated At : 02:29 PM Apr 01, 2022 IST

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits

Yearly Premium ₹999 ₹349/Year

Yearly Premium $49 $24.99/Year

London, March 31

Pharmaceutical developer Novavax says it has asked the European Medicines Agency to extend the authorisation of its Covid vaccine to children aged 12 to 17.

In a statement on Thursday, Novavax said its request was based on data from research in more than 2,200 adolescents aged 12 to 17 in the US, which found its vaccine to be about 80 per cent effective against Covid. The study was done when the delta variant was the predominant virus in the US. The EU drug regulator gave Novavax’s two-dose Covid vaccine for adults the green light in December; the shot has also been cleared by Indonesia, Australia and the WHO. — AP

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is run by a trust comprising five eminent persons as trustees.

The Tribune, the largest selling English daily in North India, publishes news and views without any bias or prejudice of any kind. Restraint and moderation, rather than agitational language and partisanship, are the hallmarks of the newspaper. It is an independent newspaper in the real sense of the term.

The Tribune has two sister publications, Punjabi Tribune (in Punjabi) and Dainik Tribune (in Hindi).

Remembering Sardar Dyal Singh Majithia

Designed and developed by : SORTD

Unlock Exclusive Insights with The Tribune Premium

Suggested Articles